ArticleClinical and experimental dermatology2022
Abrupt onset of Sweet syndrome, pityriasis rubra pilaris, pityriasis lichenoides et varioliformis acuta and erythema multiforme: unravelling a possible common trigger, the COVID-19 vaccine.
Article in Clinical and experimental dermatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Sweet syndrome induced by SARS-CoV-2 vaccines: A systematic review of patient-report studies.Human vaccines & immunotherapeutics · 2023Pooled it
- Global prevalence and clinical manifestations of cutaneous adverse reactions following COVID-19 vaccination: A systematic review and meta-analysis.Journal of the European Academy of Dermatology and Venereology : JEADV · 2022Pooled it
- SARS-CoV-2 vaccine-related cutaneous manifestations: a systematic review.International journal of dermatology · 2022Pooled it
- Pityriasis Lichenoides: Comparison of Two Pediatric Patients and Its Relationships With Vaccines and Infections.Clinical case reports · 2026Article
- Cutaneous reactions to vaccination.Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG · 2025Review
- Erythroderma Following Pfizer-BioNTech COVID-19 Vaccination in a Patient With Atopic Dermatitis: A Case Report.Cureus · 2024Article
- Article
- Pityriasis following COVID-19 vaccinations: a systematic review.Dermatology reports · 2024Article
- Pityriasis Rubra Pilaris: An Updated Review of Clinical Presentation, Etiopathogenesis, and Treatment Options.American journal of clinical dermatology · 2024Review
- Sweet syndrome following the ChAdOx1-S vaccine.BMJ case reports · 2024Article
- Erythrodermic pityriasis rubra pilaris following SARS-CoV-2 vaccination treated with bimekizumab.JAAD case reports · 2023Article
- Pityriasis rubra pilaris following COVID-19 vaccination successfully treated with ixekizumab.JAAD case reports · 2023Article
- Occurrence of erythema multiforme following COVID-19 vaccination: a review.Clinical and experimental vaccine research · 2023Review
- Pityriasis Lichenoides Following SARS-CoV-2 Infection/Vaccination.Current dermatology reports · 2023Review
- Pityriasis rubra pilaris (type I) following administration of the BNT162b2 mRNA COVID-19 vaccine: Successful treatment with ustekinumab and acitretin.Dermatologic therapy · 2022Article
- A case of pityriasis lichenoides et varioliformis acuta developed after first dose of Oxford-AstraZeneca COVID-19 vaccine.Journal of the European Academy of Dermatology and Venereology : JEADV · 2022Article
- Pityriasis lichenoides chronica induced by COVID-19 messenger RNA vaccination.JAAD case reports · 2022Article
- Covid-19 and Covid-19 vaccine can slide along sides: a report of two cases of unilateral periflexural exanthema.Journal of the European Academy of Dermatology and Venereology : JEADV · 2022Article
- Pityriasis Lichenoides et Varioliformis Acuta as a Complication of COVID-19 Infection.Dermatopathology (Basel, Switzerland) · 2022Article
- Pityriasis rubra pilaris (type I) following ChAdOx1 COVID-19 vaccine: A report of two cases with successful treatment with oral isotretinoin.Journal of the European Academy of Dermatology and Venereology : JEADV · 2022Article
Corrections and comments
- Commented on by
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.